Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer
Nancy Gavert, Yaara Zwang, Roi Weiser, Orli Greenberg, Sharon Halperin, Oded Jacobi, Giuseppe Mallel, Oded Sandler, Adi Jacob Berger, Erez Stossel, Daniil Rotin, Albert Grinshpun, Iris Kamer, Jair Bar, Guy Pines, Daniel Saidian, Ilan Bar, Shay Golan, Eli Rosenbaum, Andrei NaduEytan Ben-Ami, Rony Weitzen, Hovav Nechushtan, Talia Golan, Baruch Brenner, Aviram Nissan, Ofer Margalit, Dov Hershkovitz, Guy Lahat, Ravid Straussman*
Research output: Contribution to journal › Article › peer-review
23Scopus
citations
Fingerprint
Dive into the research topics of 'Ex vivo organotypic cultures for synergistic therapy prioritization identify patient-specific responses to combined MEK and Src inhibition in colorectal cancer'. Together they form a unique fingerprint.